Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accumulated Expenses (2021 - 2025)

Lucid Diagnostics' Accumulated Expenses history spans 5 years, with the latest figure at $2.7 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 3.89% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, down 3.89%, while the annual FY2025 figure was $2.7 million, 3.89% down from the prior year.
  • Accumulated Expenses reached $2.7 million in Q4 2025 per LUCD's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.8 million in Q4 2024 to a low of $10000.0 in Q4 2022.
  • Average Accumulated Expenses over 5 years is $1.2 million, with a median of $901000.0 recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: plummeted 98.2% in 2022, then skyrocketed 2846.88% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $557000.0 in 2021, then tumbled by 98.2% to $10000.0 in 2022, then skyrocketed by 860.0% to $96000.0 in 2023, then surged by 2846.88% to $2.8 million in 2024, then fell by 3.89% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Accumulated Expenses are $2.7 million (Q4 2025), $2.8 million (Q4 2024), and $96000.0 (Q4 2023).